Homo sapiens Protein: DNAJC6 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-99465.7 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | DNAJC6 | ||||||||||||||||||
Protein Name | DnaJ (Hsp40) homolog, subfamily C, member 6 | ||||||||||||||||||
Synonyms | DJC6; PARK19; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000360108 | ||||||||||||||||||
InnateDB Gene | IDBG-99461 (DNAJC6) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Recruits HSPA8/HSC70 to clathrin-coated vesicles and promotes uncoating of clathrin-coated vesicles. Plays a role in clathrin-mediated endocytosis in neurons (By similarity). {ECO:0000250}. | ||||||||||||||||||
Subcellular Localization | |||||||||||||||||||
Disease Associations | Parkinson disease 19, juvenile-onset (PARK19) [MIM:615528]: A juvenile form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK19 is characterized by onset of parkinsonian symptoms in the first or second decade of life. Some patients may have additional neurologic features, including mental retardation and seizures. {ECO:0000269PubMed:22563501, ECO:0000269PubMed:23211418}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Expressed in various brain regions, including cerebellum, corpus callosum, cortex, striatum, brainstem, pons, putamen, spinal cord and substantia nigra. Very low expression in non-neural tissues such as leukocytes, liver, adipose tissue, skeletal muscle and bone marrow. {ECO:0000269PubMed:23211418}. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR000008
C2 domain IPR000387 Protein-tyrosine/Dual specificity phosphatase IPR001623 DnaJ domain IPR014020 Tensin phosphatase, C2 domain IPR029021 Protein-tyrosine phosphatase-like IPR029023 Tensin phosphatase, lipid phosphatase domain |
||||||||||||||||||
PFAM |
PF00168
PF00226 PF10409 |
||||||||||||||||||
PRINTS |
PR00360
PR00625 |
||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00239
SM00271 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | O75061 | ||||||||||||||||||
PhosphoSite | PhosphoSite-O75061 | ||||||||||||||||||
TrEMBL | |||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 9829 | ||||||||||||||||||
UniGene | Hs.647643 | ||||||||||||||||||
RefSeq | NP_001243793 | ||||||||||||||||||
HUGO | HGNC:15469 | ||||||||||||||||||
OMIM | 608375 | ||||||||||||||||||
CCDS | CCDS58004 | ||||||||||||||||||
HPRD | 16326 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AB007942 AC119800 AK296408 AL139294 AL355487 AL356212 BC051722 BC109279 BC109280 CH471059 | ||||||||||||||||||
GenPept | AAH51722 AAI09280 AAI09281 BAA32318 BAH12344 CAI18997 CAI18999 CAI23547 CAI23548 EAX06533 EAX06534 EAX06536 EAX06537 | ||||||||||||||||||